WCN26-7927 A CASE OF ANTI-NEPHRIN AUTOANTIBODIES POSITIVE FSGS RECURRING IMMEDIATELY AFTER KIDNEY TRANSPLANTATION, WITH DARATUMUMAB ADMINISTRATION FAILING TO PREVENT RENAL FUNCTION LOSS

Read full text Summarise with VIRAT
Authors: REI TANITA, REI AKIYOSHI, Atsunori Yoshino, Yoko Shirai, Motoshi Hattori, Kenichiro Miura, TETSURO TAKEDA
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Although immunosuppressive agents are expected to be effective in anti-nephrin antibody-positive FSGS, recurrence after kidney transplantation can occur even with B-cell depletion therapy, suggesting the possibility of antibody production by plasma cells. This paper reports on a case of FSGS recurrence after transplantation treated with CD38 monoclonal antibody.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Renal Transplantation Outcomes and Treatments Systemic Lupus Erythematosus Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105540–105540
Publication date
25 March 2026
Language
EN